High Incidence of Herpes Zoster After Cord Blood Hematopoietic Cell Transplant Despite Longer Duration of Antiviral Prophylaxis.

导出 OA

翻译打印收藏纠错

第一作者： Elisabetta,Xue

第一单位： Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.;Hematology and Bone Marrow Transplant Unit, San Raffaele Scientific Institute, Istituto di Ricovero e Cura a Carattere Scientifico, Milan, Italy.

作者： Elisabetta,Xue ^[1] ; Hu,Xie ^[2] ; Wendy M,Leisenring ^[2] ; Louise E,Kimball ^[3] ; Sonia,Goyal ^[3] ; Lisa,Chung ^[3] ; Rachel,Blazevic ^[3] ; Byron,Maltez ^[3] ; Anna,Edwards ^[2] ; Ann E,Dahlberg ^[2] ; Rachel B,Salit ^[2] ; Colleen,Delaney ^[4] ; Steven A,Pergam ^[5] ; Michael,Boeckh ^[5] ; Filippo,Milano ^[2] ; Joshua A,Hill ^[5]

作者单位： Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.;Hematology and Bone Marrow Transplant Unit, San Raffaele Scientific Institute, Istituto di Ricovero e Cura a Carattere Scientifico, Milan, Italy. ^[1] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. ^[2] Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. ^[3] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.;Nohla Therapeutics, Seattle, Washington, USA. ^[4] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.;Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. ^[5]

关键词 antiviral cord blood hematopoietic cell transplant prophylaxis varicella zoster virus